Retour à l'accueil
Inscrivez-vous, c'est gratuit
Accès membre
Consultez nos palmarès de valeurs
La newsletter sur l'actualité de la bourse
Dimanche 5 juillet 2009

Merck and Company   MRK - [isin US5893311077]

Imprimer le contenu de cette page Envoyer cette page à un ami

EU Panel: Keeps Stance That Gardasil Benefits Outweigh Risks

Thursday January 24th, 2008 / 17h32
Edited Press Release ZURICH -(Dow Jones)- An advisory body of the European Union Thursday said it still believes benefits associated with Merkc & Co's (MRK) human papillomavirus-vaccine Gardasil outweigh the risks.
The European Medicines Agency said it has received reports of deaths in women who had previously received Gardasil, including two reports concerning the sudden and unexpected deaths of two young women in the European Union.
Gardasil is a vaccine approved in the EU for the prevention of cervical cancer and other diseases caused by human papillomavirus types 6, 11, 16 and 18. It is estimated that about 1.5 million patients have been vaccinated with this HPV vaccine in Europe.
The two European cases were reported as part of the continuous monitoring of the safety of medicines. One of the cases occurred in Austria and the other in Germany. In both cases, the cause of death could not be identified. No causal relationship has been established between the deaths of the young women and the administration of Gardasil.
On the basis of the currently available evidence, the EMEA's Committee for Medicinal Products for Human Use (CHMP) is of the opinion that the benefits of Gardasil continue to outweigh its risks and that no changes to its product information are necessary.
The EMEA will continue to closely monitor the safety of Gardasil and take appropriate actions should new information emerge that has an impact on the benefit-risk profile of Gardasil.
Company Web Site: http://www.emea.europa.eu
-Zurich Bureau, Dow Jones Newswires; +41 43 443 8040; zurichdjnews@dowjones.com
Thursday January 24th, 2008 / 17h32 Source : Dowjones Business News
News sur la société Suite des news >>
01/07 Argentina's May Leading Index +1.4% On Mo; -16.9%... (DJ - 17h04)
01/07 WHO, Wyeth To Start Clinical Trial On New River... (DJ - 17h03)
29/06 Merck Resolves Shipping Delays For Shingles Vaccine (DJ - 16h07)
25/06 UPDATE: Sanofi To Fill US Vaccine Supply Gap... (DJ - 20h24)
25/06 Top US Senate Democrat Supports Action Against... (DJ - 20h24)
News sectorielles
03/07 Sanofi-aventis : en tête du CAC, priorité aux... (CF - 11h24)
03/07 Sanofi: Pic des ventes de Multaq vu à EUR1md-JPM (DJ - 10h06)
02/07 Sanofi-Aventis prévoit de lancer le Multaq aux... (DJ - 18h25)
02/07 4th UPDATE: Sanofi-Aventis' Multaq Drug Approved... (DJ - 17h21)
02/07 3rd UPDATE: Sanofi-Aventis' Multaq Drug Approved... (DJ - 16h03)
Cours : 19,14 €
Var.: -1,09 %
Perf.: +1.16 %
Depuis 5 jours
Profil Société
Activité
Merck and Company est sp écialisé dans le développement, la fabrication et la commercialisation de produits thérapeutiques et de vaccins vendus sous...
>> Suite
Prévisions
Aucune information sur
les données prévisionnelles n'est disponible
>> Suite
Chiffres clés
Aucune information sur
les chiffres clés n'est disponible
>> Suite
Actionnaires
Aucune information sur
l'actionnariat n'est disponible
>> Suite
Consensus
Achat
 0%
Conserver
 0%
Vendre
 0%
Aucun objectif de cours
n'est disponible
Aucune information sur
les données prévisionnelles n'est disponible
Accédez au forum de la valeur « merck-and-company »
Les derniers messages
Médicaments génériques: le...
posté par easy le 22/02 à 18h42
La menace des génériques incitent le JDF à patienter
posté par roger le 09/12 à 16h11
 
Contactez-nous Mentions légales Partenaires techniques et prestataires
Copyright © 2008 Easybourse.com - Tous droits réservés.   Euronext: cours différés d'au moins 15 minutes
index des interviews | index des infos | index des rumeurs | index des deals | index des chiffres & stats | index des dossiers | index des études graphiques | index des interviews vidéos
Partenaires : bourse, technologies mobiles, broker forex, diamants, quotidien financier, promo auto, web francophone, chèques cadeau, voyages, Le diagnostic immobilier, finance étudiant
Bourse